Several functional and structural modifications at the vascular level have been described in spontaneously hypertensive rats (SHR) during the early development of hypertension. In this study, we hypothesize that changes in the extracellular matrix (ECM) could precede the development of hypertension. Synthesis of secreted and membrane-bound sulfated proteoglycans (S-PG) by cultured vascular smooth muscle cells (VSMC) obtained from young spontaneously hypertensive rats (pSHR) mesenteric resistance arteries, during the period preceding the elevation of blood pressure (BP) was tested. After 24 h of stimulation with angiotensin II (Ang II), 10% fetal calf serum (FCS), or 0.1% FCS as control, medium and cell layer S-PG synthesis was evaluated by labeling sulfated disaccharides with [
T he extracellular matrix (ECM) is the structural and functional support to which cells adhere and on which they grow, migrate, and differentiate. The ECM of the blood vessel wall contains elastin, collagen, and proteoglycans (PG) and it behaves as a biologically active system, with a balance of components that is necessary for the normal functioning of the vasculature. 1 Changes in ECM components can affect vascular resistance and hence blood pressure (BP) by virtue of their biomechanical properties. 2 It is known that alterations of ECM in the vascular wall contribute to the narrowing of arteries and lead to the development of complications of hypertension. 3 The amount and organization of smooth muscle cells and the ECM in the tunica media of resistance arteries regulate peripheral resistance; therefore, defects in matrix composition or distribution may contribute to the development or maintenance of hypertension. 4 In addition, changes in the arterial wall do not necessarily result from increased BP alone, and especially the latter observation indicates that part of the pressure-independent changes in the vessel wall may be due to alterations in ECM components. 5 The ECM PG, nonfibrillar matrix components that carry glycosaminoglycans, are synthetized by vascular smooth muscle cells (VSMC) in response to growth factors 6 and have been found to play an important role in VSMC growth and differentiation. 7 Angiotensin II (Ang II) is a regulator of vascular tone as well as a vascular cell growth. Previous studies suggest that there may be a close link between Ang II and ECM proteins, based on the evidence that Ang II, by way of the AT 1 receptor, may contribute to the enhanced gene expression of various ECM components in the heart and blood vessels of hypertensive rats. 8 The Ang II may also regulate vascular collagen metabolism, increasing collagen synthesis in VSMC of different origins. 9, 10 Previously, we have found different profiles of PG synthesis induced by various growth factors in mesenteric VSMC from adult 12-to 14-week-old spontaneously hypertensive rats (SHR) with an established chronic BP elevation or age-matched normotensive Wistar rats. 11 In those experiments, Ang II was the only factor that produced a greater amount of sulfated membrane-bound PG in SHR cells than in those from Wistar rats.
In the present study, we hypothetize that changes in ECM production or composition could precede the development of hypertension. Therefore, we tested the synthesis of secreted and membrane-bound sulfated PG (S-PG) by cultured VSMC obtained from young SHR mesenteric resistance arteries during the period preceding the elevation of BP.
Methods
Young male (3-to 4-week-old) SHR (n ϭ 8) and agematched Wistar control rats (n ϭ 8) were used for this study. Wistar rats were selected as normotensive controls to use the same strain as in a previous study. 11 The SHR were acquired from the Veterinary School of La Plata University, Argentina. The rats were housed under standard conditions of controlled temperature (20°C) and humidity (60%) and a 12-h light/dark cycle. Animals were fed regular commercial pelleted rat chow and given tap water ad libitum. All procedures were performed in accordance with institutional guidelines for animal experimentation (Animal Experimentation Committee, School of Medicine, Universidad Nacional de Cuyo). Systolic BP was monitored indirectly in conscious prewarmed, slightly restrained rats by the tail-cuff method and recorded on a Grass model 7 polygraph (Grass Medical Instruments, Quincy, MA). The average of three pressure readings was recorded. Young prehypertensive SHR (pSHR) had a systolic BP (116.2 Ϯ 3.7 mm Hg; n ϭ 8) that was not significantly different than that of age-matched normotensive Wistar rats (pW) (104.0 Ϯ 4.0 mm Hg; n ϭ 8).
Cell Culture
Unless otherwise noted, all reagents were obtained from Sigma Chemical Co. (St. Louis, MO). The animals were killed by decapitation under ether anesthesia, and the mesenteric SMC were isolated according to a technique previously described. 12 Briefly, entire mesenteric arcades, excluding the superior mesenteric arteries, were aseptically excised and placed in chilled HBSS with an antibiotic mixture for further dissection. Mesenteric arcades, cleaned of connective tissue and fat, were minced and digested in a 37°C shaker bath with the following enzyme mixture: 2 mg/mL collagenase (Worthington Biochemical Corp., Lakewood, NJ), 0.15 mg/mL elastase, 2 mg/mL BSA, and 0.35 mg/mL soybean trypsin inhibitor in Ham's F-12 medium. After 2 h, a cell suspension was obtained. Cells were grown in 10% fetal calf serum (FCS) (Gen S.A., Buenos Aires, Argentina) and MEM/F-12 incubated at 37°C under humid 5% CO 2 /air conditions. Mesenteric SMC between the fourth and sixth passages were used for the experiments. Although cultured mesenteric VSMC exhibited the characteristic hill-and-valley growth pattern on reaching confluence, cultures were identified by the presence of positive staining with antismooth muscle "␣-actin. A negative staining with antifactor VIII antibodies (Sigma Chemical Co.) assessed a complete removal of endothelial cells from mesenteric arteries.
Sulfated Proteoglycan Evaluation
The S-PG were extracted and measured with techniques already described 11 in cultured VSMC medium and cell layer, labeling sulfated disaccharides by incubating with 
Isolation of S-PG: S-PG Secreted into the Medium
The medium was removed from each plate, and the total volume was applied to a disposable Sephadex G-50 gel filtration column equilibrated and run in 4 mol/L guanidine hydrochloride, 0.05 mol/L sodium acetate (pH 6.0) and 2% (wt/vol) Triton X100. The corresponding eluted fraction was collected and analyzed for radioactivity.
Pericellular Matrix: Total Cell-Associated S-PG The cell layer was rinsed in HBSS and extracted in 1 mL of 4 mol/L guanidine hydrochloride, 0.05 mmol/L sodium acetate (pH 6.0), and 2% (wt/vol) Triton X100. The solution containing the detached cells was applied to a chromatography disposable Sephadex G-50 column, as described above. In every experiment, aliquots of cell extracts were used for protein determination (Bradford method). Labeled [
35 S]PG were detected in medium or cell extract by counting in a liquid scintillation counter (Beta Rack LKB) and results expressed as cpm per microgram of protein.
Measurement of DNA Synthesis
For measurements of cell proliferation, mesenteric SMC from pSHR and pW were plated in 24-well plates (2 ϫ 10 4 cells per well) and allowed to grow until 80% confluence was reached. Cells were made quiescent by replacing the medium with 0.1% FCS/F-12 MEM for 48 h. Then they were incubated for 24 h with 10% FCS, 100 nmol/L Ang II, or 0.1% FCS as control group in F-12 MEM. Cells were pulsed with 1.0 mCi/mL [ 3 H]thymidine (New England Nuclear, Boston, MA) during the last 3 h before the end of the incubation period. After washing the cells with cold PBS, DNA was precipitated with 10% trichloroacetic acid and finally solubilized with 0.1% sodium dodecylsulfate and 0.1 mol/L sodium hydroxide. Aliquots of the extract were counted in a scintillation counter. Data from the proliferation assays are expressed as cpm per micrograms of protein (Lowry microassay) in the cell lysate.
Statistical and Data Analysis
Data are presented as mean Ϯ SEM. The statistical significance was assessed with Student t test for comparison of values from two samples or one-way ANOVA and a Newman Keuls post test when more than two sample averages were compared. A P value less than .05 was considered statistically significant.
Results
The basal and stimulated with Ang II or 10% FCS secreted and membrane-bound sulfated PG production were examined in cultured mesenteric VSMC from SHR in a period previous to the BP elevation (3-to 4-week old) and agematched normotensive Wistar rats. Fig. 1A shows the results when secreted into the medium S-PG were measured in basal conditions, incubated with 0.1% FCS as control, or in stimulated conditions, incubated with Ang II or 10% FCS. The VSMC from pSHR displayed a significantly greater amount of extracellular [
35 S]-labeled PG than those of control rats, in both basal and stimulated with Ang II or 10% FCS.
The results obtained when membrane-bound S-PG (pericellular matrix) were measured in VSMC and are shown in Fig. 1B . There was also a significantly greater S-PG synthesis in VSMC from pSHR than in those of control rats, in basal as well as those incubated with Ang II or 10% FCS.
A different pattern of response to Ang II and 10% FCS between VSMC of pSHR and pW (Fig. 2) was detected in both secreted into the medium and cell-associated S-PG content when data are expressed as percent of their own control (0.1% FCS). In VSMC from control normotensive rats, extracellular [
35 S]-labeled PG increased significantly in the presence of 10% FCS but not with Ang II, compared with the 0.1% control group (Fig. 2A) . Cell-associated S-PG showed a small nonsignificant increase in response to 10% FCS and no change with Ang II. However, in pSHR cells, 10% FCS produced a significant decrease in both medium and cell layer (Ϫ37.43% and Ϫ54.60%, respectively), and Ang II a significant decrease in cellassociated PG (Ϫ40.50%) (Fig. 2B) .
In all cases, the majority of sulfated PG was secreted into the medium, retaining only about 20% of the cell layer. This proportion did not significantly differ between pSHR and pW cells in any case, except for a significantly lower relative accumulation of PG in the cell layer in pSHR cells incubated with 10% FCS (pSHR: 17.3% Ϯ 1.2%; pW: 22.6% Ϯ 1.2%; P Ͻ .05).
To assess whether total S-PG production (secreted plus membrane bound) was associated with cell proliferation, DNA synthesis was determined by [ 3 H]thymidine incorporation. Fig. 3 shows the results of [ 3 H]thymidine incorporation and total sulfated PG production. Ang II and 10% FCS treatments induced a significant increase in [ 3 H]thymidine incorporation, both in pW and in pSHR cells, compared with the respective control treatment. This proliferative effect of growth factors was significantly greater in VSMC from pSHR than in pW cells. However, total S-PG synthesis followed a different pattern. In pW cells,
FIG. 1. Synthesis of S-PG measured by the uptake of [
35 S]sodium sulfate, secreted into the medium (A) and bound to the membrane (B), by cultured VSMC from pSHR and pW rats, incubated with 0.1% FCS (control group), 100 nmol/L Ang II, or 10% FCS. Data are mean Ϯ SEM, n ϭ 6 in all groups. *P Ͻ .05, **P Ͻ .01, and ***P Ͻ .001 v Wistar rat cells. FCS ϭ fetal calf serum; Ang II ϭ angiotensin II; pW ϭ age-matched Wistar rat; pSHR ϭ young spontaneously hypertensive rats; S-PG ϭ sulfated proteoglycans; VSMC ϭ vascular smooth muscle cells.
total PG synthesis did not change in response to Ang II and significantly increased when incubated with 10% FCS, compared with 0.1% FCS in the control group. Instead, in pSHR cells, and despite PG synthesis was greater than in pW cells, both Ang II and 10% FCS significantly diminished total S-PG synthesis with respect to the basal group.
Discussion
Increased peripheral resistance generated by a narrowed lumen diameter is the main change leading to BP elevation in essential hypertension. It is likely that the interaction between functional and structural components may be important during the undergoing from the prehypertensive phase to the phase of established hypertension. Several functional and structural changes at the vascular level have been described in SHR during the early development of hypertension. Some of these changes are alterations in functional aortic wall properties, such as lower compliance and distensibility in young 1.5-month-old SHR 5 ; a blunted aortic contractile response to endothelin-1, norepinephrine, and vasopressin and a greater response to norepinephrine and vasopressin of mesenteric resistance arteries in prehypertensive SHR 13 ; significant vascular hypertrophy, enhanced angiotensin II-stimulated responsiveness of small mesenteric arteries and increased vascular expression of AT 2 receptor mRNA 14, 15 ; a greater media thickness and media:lumen ratio of mesenteric small arteries in 4-week-old SHR 16 ; increased contractile response to various agonists, mesenteric vasculature medial hypertrophy, and increased smooth muscle cell length in 3-to 4-weekold SHR 17 ; and mesenteric arteries eutrophic remodeling with a lower expression of ␣ 5 ␤ 1 integrins in 6-week-old SHR. 18 Defects in matrix composition or distribution may contribute to the development or maintenance of hypertension. 19 Using morphometric techniques, 20 a difference in matrix parameters, such as greater collagen and ground substance and lesser basement membrane content in small mesenteric vessels from male 27-week-old SHR, compared with control rats, has been found. Changes in VSMC PG have also been described in SHR, such as more sulfated PG synthesis in 10-and 28-week-old SHR carotid arteries 21 and different profiles of PG synthesis in mesenteric smooth muscle cells from adult 12-to 14-week-old SRH compared with normotensive age-matched Wistar rats. 11 It is known that Ang II, through its autocrine/ paracrine properties, influences the vascular wall by modulating cell growth and contributing to biological responses involving ECM and other connective tissues. 22 It has been shown that Ang II evoked an increase in PG production in cultured VSMC of adult Sprague-Dawley normal rats 23 and adult SHR. 11, 24 The present study was designed to examine the basal and stimulated synthesis of secreted and membrane-bound sulfated PG in cultured VSMC from mesenteric resistance arteries of young SHR. We used VSMC obtained from SHR at an age that corresponds to the first stage of hypertension or the prehypertensive period, as described by Okamoto and Aoki in their early work. 25 Considering that changes in small arteries play a more important role in the development of systemic hypertension, contributing to the increase of peripheral vascular resistance, we chose the mesenteric vascular bed as representative of resistance arteries. Sulfated PG were measured in both the cell layer and medium, as the medium does not necessarily reflect the conditions of the cell layer. We agree with Thogersen et al 26 in considering the cell layer of cultured arterial SMC together with its associated extracellular matrix is a model of the arterial wall. Besides, the use of cultured VSMC allows us to study PG synthesis by the tunica media, excluding synthesis by other vascular wall components.
In both basal and stimulated Ang II or 10% FCS, we found a significantly greater amount of extracellular and pericellular sulfated PG in VSMC from 3-to 4-week-old SHR than in cells from age-matched normotensive control rats. Expressing data as a percent of the basal nonstimu- lated synthesis, there was a difference in the effect of Ang II and 10% FCS on PG production between cells obtained from young SHR and normotensive rats. A decrease in secreted and membrane-bound S-PG with 10% FCS and Ang II was observed in VSMC from pSHR, whereas in pW rat cells, PG synthesis increased or did not change. Several actions of vascular PG has been described, such as inhibition of neointimal formation and VSMC proliferation 27 and regulation of VSMC migration by heparan sulfate, 28 or contribution of chondroitin-dermatan sulfate to the functional behavior of resistance arteries. 29 We can speculate that, by these or other actions, the early changes of S-PG in resistance artery VSMC in SHR, before BP elevation, could be a factor that contributes to changes in the vascular wall, which precedes the development of hypertension.
Extracellular matrix represents an important regulatory mechanism that modulates the nature of the VSMC growth response. 30 Because it has been hypothetized that ECM PG may influence the growth and proliferation, we examined the relationship between S-PG synthesis and proliferation. It has been extensively reported that PG, due to their highly negative charge, bind to several growth factors and function as modulators of growth factors. 31, 32 Vascular wall PG can participate in the process of cell division in two ways, either acting as a positive or negative modulator, or as a response to mitogenic stimulus. 33 Our results show that, when total S-PG production was related to basal and stimulated cell proliferation, assessed by the incorporation of [ 3 H]thymidine into newly synthetized DNA, an inverse relationship between these two variables was found in prehypertensive SHR cells, but not in normotensive rat cells. In VSMC from normotensive animals, a small proliferative effect induced by both Ang II and 10% FCS was accompanied by a nonmodified or higher S-PG production. Instead, in prehypertensive SHR cells the marked proliferative effect of both growth factors correlated with a reduced S-PG synthesis. These results support the idea that PG production and the proliferative state are not always synchronous, as has been previously suggested by other researchers. 6, 34 Angiotensin II has been found to stimulate hyperplasia, hypertrophy, and antiapoptotic effects, depending on the VSMC type, and this plasticity of the VSMC growth response to Ang II represents the interplay of different mechanisms, including changes in cell matrix. 30 Studies in animal models, as well as clinical studies, support a strong role for locally generated Ang II in several organs, including the vessels, and in the pathogenesis of cardiovascular diseases. Presumably, vascular injury induced by locally generated Ang II is independent of changes in BP and reflects a direct change in VSMC growth. 1, 35 In the present study, Ang II stimulated DNA synthesis, in accordance with other reports, 36, 37 with a greater effect on SHR cells. Our results raise the possibility that the greater proliferative response to Ang II in VSMC from prehypertensive SHR may be due, at least in part, to their ability to reduce S-PG production and we can speculate that this may be a mechanism by which locally generated angiotensin and other growth factors participate in the generation of early changes in VSMC of the resistance arteries wall changes in SHR.
In summary, the present results indicate that changes in PG modulation in VSMC of resistance vessels precede the development of hypertension in SHR and may indicate a pathophysiologic role in the vascular wall changes associated to the early BP elevation phase in genetically hypertensive rats.
FIG. 3.
Relationship between total PG synthesis (secreted plus membrane-bound) and [ 3 H]thymidine incorporation into newly synthesized DNA by cultured VSMC from pSHR and pW rats, incubated with 0.1% FCS (control group), 100 nmol/L Ang II, or 10% FCS. Data are mean Ϯ SEM, n ϭ 6 in all groups. **P Ͻ .01, ***P Ͻ .001 v 0.1% FCS control group. *P Ͻ .05, ***P Ͻ .001 v Wistar rat cells. Abbreviations as in Figs. 1 and 2 .
